ATE88902T1 - Polyprenylverbindung enthaltende zusammensetzung fuer weiche kapseln. - Google Patents

Polyprenylverbindung enthaltende zusammensetzung fuer weiche kapseln.

Info

Publication number
ATE88902T1
ATE88902T1 AT90112251T AT90112251T ATE88902T1 AT E88902 T1 ATE88902 T1 AT E88902T1 AT 90112251 T AT90112251 T AT 90112251T AT 90112251 T AT90112251 T AT 90112251T AT E88902 T1 ATE88902 T1 AT E88902T1
Authority
AT
Austria
Prior art keywords
soft capsules
composition
capsules containing
polyprenyl compound
containing polyprenyl
Prior art date
Application number
AT90112251T
Other languages
German (de)
English (en)
Inventor
Keizo Uesugu
Masanori Kayano
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of ATE88902T1 publication Critical patent/ATE88902T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT90112251T 1989-07-10 1990-06-27 Polyprenylverbindung enthaltende zusammensetzung fuer weiche kapseln. ATE88902T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP17732489 1989-07-10
EP90112251A EP0407815B1 (en) 1989-07-10 1990-06-27 Polyprenyl compound composition for soft capsules

Publications (1)

Publication Number Publication Date
ATE88902T1 true ATE88902T1 (de) 1993-05-15

Family

ID=16028989

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90112251T ATE88902T1 (de) 1989-07-10 1990-06-27 Polyprenylverbindung enthaltende zusammensetzung fuer weiche kapseln.

Country Status (13)

Country Link
US (1) US5139740A (enExample)
EP (1) EP0407815B1 (enExample)
JP (1) JP3048602B2 (enExample)
KR (1) KR930000048B1 (enExample)
CN (1) CN1041600C (enExample)
AT (1) ATE88902T1 (enExample)
CA (1) CA2020261A1 (enExample)
DE (1) DE69001513T2 (enExample)
DK (1) DK0407815T3 (enExample)
ES (1) ES2055227T3 (enExample)
FI (1) FI96169C (enExample)
GR (1) GR3007793T3 (enExample)
NO (1) NO177484C (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI901046A7 (fi) * 1989-03-17 1990-09-18 Eisai Co Ltd Polyprenyyliyhdisteen stabiloiminen
JPH06510020A (ja) * 1991-03-29 1994-11-10 ユニバーシティ・オブ・フロリダ 混成リン酸エステル誘導体を経た標的への薬剤供給
IT1263840B (it) * 1993-03-30 1996-09-04 Giuseppe Furiosi Formulazioni orali di ubidecarenone in forma di capsule
SK74699A3 (en) * 1996-12-12 2000-02-14 Upjohn Co An oil composition of dihydropolyprenols
US6013280A (en) * 1997-10-07 2000-01-11 Fuisz Technologies Ltd. Immediate release dosage forms containing microspheres
KR101152470B1 (ko) 2003-08-13 2012-06-01 바이오콘 리미티드 치료제용 마이크로-입자 지방산 염 고형 투약 제형
WO2013049749A2 (en) * 2011-09-29 2013-04-04 Plx Pharma Inc. pH DEPENDENT CARRIERS FOR TARGETED RELEASE OF PHARMACEUTICALS ALONG THE GASTROINTESTINAL TRACT, COMPOSITIONS THEREFROM, AND MAKING AND USING SAME
KR20220158031A (ko) 2020-03-26 2022-11-29 피엘엑스 옵코 인코포레이티드 pH 의존성 재구성이 가능한 제약 담체 및 그의 제조 및 사용 방법
WO2025219169A1 (en) 2024-04-16 2025-10-23 Bayer Consumer Care Ag Stable soft capsule preparations with liquid fill for moisture sensitive active ingredients

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2746087A1 (de) * 1977-10-13 1979-04-26 Chinoin Gyogyszer Es Vegyeszet Cyclodextrin-einschlusskomplexe mit indomethacin, verfahren zu ihrer herstellung und pharmazeutische mittel
JPS5815940A (ja) * 1981-07-23 1983-01-29 Eisai Co Ltd ポリプレニル系化合物およびその製造方法ならびにそれを含有する医薬
DE3500103C2 (de) * 1985-01-04 1987-01-22 R.P. Scherer GmbH, 6930 Eberbach Pharmazeutische Zubereitung mit einem in Wasser und Verdauungssäften schwer löslichen Wirkstoff
IE59067B1 (en) * 1985-04-02 1993-12-15 Yesair David W Composition for delivery of orally administered drugs and other substances
GB8630273D0 (en) * 1986-12-18 1987-01-28 Til Medical Ltd Pharmaceutical delivery systems

Also Published As

Publication number Publication date
NO903058L (no) 1991-01-11
NO177484B (no) 1995-06-19
EP0407815B1 (en) 1993-05-05
FI903030A0 (fi) 1990-06-15
JP3048602B2 (ja) 2000-06-05
EP0407815A2 (en) 1991-01-16
NO903058D0 (no) 1990-07-09
ES2055227T3 (es) 1994-08-16
JPH03128322A (ja) 1991-05-31
EP0407815A3 (en) 1991-02-27
KR930000048B1 (ko) 1993-01-06
CN1048656A (zh) 1991-01-23
NO177484C (no) 1995-09-27
DE69001513T2 (de) 1993-10-28
FI96169C (fi) 1996-05-27
DK0407815T3 (da) 1993-06-01
US5139740A (en) 1992-08-18
FI96169B (fi) 1996-02-15
DE69001513D1 (de) 1993-06-09
CN1041600C (zh) 1999-01-13
CA2020261A1 (en) 1991-01-11
GR3007793T3 (enExample) 1993-08-31
KR910002443A (ko) 1991-02-25

Similar Documents

Publication Publication Date Title
DK24389A (da) (cycloalkylamino)methylenbis(phosphonsyre) og farmaceutiske praeparater indeholdende forbindelsen
IL90271A0 (en) Antiviral drug
HUT38950A (en) Process for producing 2-substituted-1,3-propylidene-diphosphonate derivatives and pharmaceutical compositions containing them as active agents
DE69001513D1 (de) Polyprenylverbindung enthaltende zusammensetzung fuer weiche kapseln.
SE8600017D0 (sv) New compound
ES2066060T3 (es) Solucion humectada para impresion litografica.
AU1951392A (en) Naphthylamine polycarboxylic acids
CS717682A2 (en) Insekticidni a akaricidni prostredek a zpusob vyroby ucinnych latek
GR3022712T3 (en) Amino acid derivative.
ATE75933T1 (de) Zahnaerztliche haftmittelzusammensetzung.
DE69001734D1 (de) Aeusserlich anzuwendende amusulosin enthaltende arzneizubereitung.
GB8815180D0 (en) Compositions
BR9505655A (pt) Processo direto para preparação de alquíl halodifluoroacetatos
DE3877277D1 (de) Injektionszusammensetzung, die modifiziertes tpa enthaelt.
OA08746A (fr) Dérivés d'acide hydrocinnamique.
SG48093A1 (en) Process for the preparation of crystalline taca
GR3017280T3 (en) Aminoalkylchromones, process for their preparation and compositions containing them.
DE69108580D1 (de) Optisch aktives Derivat der d-2-(6-Methoxy-2-naphthyl)-propionsäure und es enthaltende pharmazeutische Zusammensetzungen.
AU1491583A (en) Optically active imidazolylpropanols
AU2169088A (en) Thionophosphonates
EP0080592B1 (en) A novel vasodilator compound, process for the preparation thereof and pharmaceutical compositions thereform
DK0387655T3 (da) Stabilisering af polyprenylforbindelse

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee